Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.33502 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.32273 | 13 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.31257 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.26927 | 13 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.26454 | 12 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.36426 | 12 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.33307 | 12 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.2913 | 12 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.2908 | 13 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.31108 | 13 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.31123 | 13 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.62496 | 29 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.31325 | 13 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.30012 | 12 |